In addition, Aloia et al. identified a subpopulation of breast cancer cells carrying high levels of SSEA-4 to be resistant to chemotherapy drugs and showed ST3GAL2 to be a marker of poor outcome in breast cancer and ovarian cancer patients undergoing chemotherapy48. This evidence concerns the gene ST3GAL2 and ovarian carcinoma.